Learn how Otsuka Pharmaceuticals accelerated development of a potentially treatment-shortening drug by partnering with Phase Advance to simulate outcomes in 10,000 virtual patients, helping support FDA approval of a streamlined single-arm trial while improving speed, cost efficiency, and patient safety.
